As the CEO of Epi One, Inc., Michael is leading a cutting-edge biotech startup that is on a mission to revolutionize early cancer detection and accurate diagnosis. With over 20 years of global experience in healthcare and technology sectors, he has a proven track record of delivering strategic vision, operational excellence, and transformative innovation. Michael is passionate about ending cancer as we know it, for everyone, after losing several loved ones to the disease. His dedication to fighting cancer led him to chair the national board of the American Cancer Society where he championed the first female CEO appointment in the organization’s 100+ year history. In addition to his role at Epi One, Michael serves as a board member and advisor for several corporations across different industries. He has chaired and served on corporate boards in Indonesia, Malaysia, France, and the United States, advising clients on global business development, corporate governance, risk management, and emerging technology challenges. Michael is also a Board Leadership Fellow of the National Association of Corporate Directors (NACD) and a Commissioner for the Future of the American Board. He holds the CERT Cybersecurity Oversight Certificate for corporate directors and has published numerous articles on governance and risk topics. He has lived and worked in Europe, Asia, and the United States. In January of 2022, President Biden appointed Michael to serve on the U.S. Commission for the Preservation of America’s Heritage Abroad.